Digoxin. The drug of choice for the in-utero treatment of paroxysmal supraventricular tachycardia.

I S Silva, C Nunes, G Mimoso, E Castela, J Mesquita

Abstract


Fetal tachyarrhythmia may constitute a risk for the fetus, therefore early treatment is indicate for all cases of tachydysrhythmia, with or without hydrops, in order to prevent irreversible hydrops. A case report is described of supraventricular paroxysmal tachycardia with digoxin in utero therapy in which pharmacological intervention was successful. Some comments are regarding the experience of the multidisciplinary team at Bissaya-Barreto Maternity in the treatment and orientation of fetal tachydysrhythmias.

Full Text:

PDF (Português)


Refbacks

  • There are currently no refbacks.